Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer

Despite their efficacy, uptake of selective estrogen receptor modulators for breast cancer chemoprevention remains low. Exemestane, an aromatase inhibitor, has recently been identified as a potential chemopreventive option with fewer serious side effects compared with selective estrogen receptor mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktas, Bilge, Sorkin, Mia, Pusztai, Lajos, Hofstatter, Erin W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Review Article: Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885537/
https://www.ncbi.nlm.nih.gov/pubmed/25642790
http://dx.doi.org/10.1097/CEJ.0000000000000124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885537/
https://www.ncbi.nlm.nih.gov/pubmed/25642790
http://dx.doi.org/10.1097/CEJ.0000000000000124

Ejemplares similares